{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:26:29Z","timestamp":1793647589705,"version":"4.5.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T00:00:00Z","timestamp":1660176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001785","name":"Flinders University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001785","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Studies of genitourinary toxicity following radiotherapy for prostate cancer are mainly from high volume single institutions and the incidence and burden of treatment remain uncertain. Hence we determine the cumulative incidence of treatment-related genitourinary toxicity in patients with localised prostate cancer treated with primary external beam radiotherapy (EBRT) at a state population level.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We analysed data from a prospective population-based cohort, including hospital admission and cancer registry data, for men with localised prostate cancer who underwent primary EBRT without nodal irradiation between 1998 and 2019 in South Australia. The 10-year cumulative incidence of genitourinary toxicity requiring hospitalisation or procedures was determined. Clinical predictors of toxicity and the volume of admissions, non-operative, minor operative and major operative procedures were determined.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>All the included patients (<jats:italic>n<\/jats:italic>\u2009=\u20093350) had EBRT, with a median (IQR) of 74\u00a0Gy (70\u201378) in 37 fractions (35\u201339). The 10-year cumulative incidence of was 28.4% (95% CI 26.3\u201330.6) with a total of 2545 hospital admissions, including 1040 (41%) emergency and 1893 (74%) readmissions. The 10-year cumulative incidence of patients in this cohort requiring a urological operative procedure was 18% (95% CI 16.1\u201319.9), with a total of 106 (4.2%) non-operative, 1044 (41%) minor operative and 57 (2.2%) major operative urological procedures.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Genitourinary toxicity after radiotherapy for prostate cancer is common. Although there continue to be advancements in radiotherapy techniques, patients and physicians should be aware of the risk of late toxicity when considering EBRT.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00345-022-04124-x","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T09:05:01Z","timestamp":1660208701000},"page":"2411-2422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Incidence of genitourinary complications following radiation therapy for localised prostate cancer"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4483-1204","authenticated-orcid":false,"given":"Rowan V.","family":"David","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2618-3266","authenticated-orcid":false,"given":"Arman A.","family":"Kahokehr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7683-2693","authenticated-orcid":false,"given":"David I.","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1834-9131","authenticated-orcid":false,"given":"John","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5038-5859","authenticated-orcid":false,"given":"Michael E.","family":"O\u2019Callaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,8,11]]},"reference":[{"issue":"5","key":"4124_CR1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","volume":"136","author":"J Ferlay","year":"2015","unstructured":"Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathers C, Rebelo M et al (2015) Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 136(5):E359\u2013E386","journal-title":"Int J Cancer"},{"issue":"9","key":"4124_CR2","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.6004\/jnccn.2012.0114","volume":"10","author":"JL Mohler","year":"2012","unstructured":"Mohler JL, Armstrong AJ, Bahnson RR, Boston B, Busby JE, D\u2019Amico AV et al (2012) Prostate cancer, Version 3.2012: featured updates to the NCCN guidelines. J Natl Compr Cancer Netw 10(9):1081\u20131087","journal-title":"J Natl Compr Cancer Netw"},{"issue":"7","key":"4124_CR3","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.1200\/JCO.2009.26.0133","volume":"28","author":"MR Cooperberg","year":"2010","unstructured":"Cooperberg MR, Broering JM, Carroll PR (2010) Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 28(7):1117\u20131123","journal-title":"J Clin Oncol"},{"issue":"1","key":"4124_CR4","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3816\/CGC.2005.n.007","volume":"4","author":"KM Kramer","year":"2005","unstructured":"Kramer KM, Bennett CL, Pickard AS, Lyons EA, Wolf MS, McKoy JM et al (2005) Patient preferences in prostate cancer: a clinician\u2019s guide to understanding health utilities. Clin Prostate Cancer 4(1):15\u201323","journal-title":"Clin Prostate Cancer"},{"issue":"1","key":"4124_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0022-5347(05)65395-5","volume":"167","author":"BG Gardner","year":"2002","unstructured":"Gardner BG, Zietman AL, Shipley WU, Skowronski UE, McManus P (2002) Late normal tissue sequelae in the second decade after high dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer. J Urol 167(1):123\u2013126","journal-title":"J Urol"},{"issue":"2","key":"4124_CR6","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S1470-2045(13)70606-5","volume":"15","author":"RK Nam","year":"2014","unstructured":"Nam RK, Cheung P, Herschorn S, Saskin R, Su J, Klotz LH et al (2014) Incidence of complications other than urinary incontinence or erectile dysfunction after radical prostatectomy or radiotherapy for prostate cancer: a population-based cohort study. Lancet Oncol 15(2):223\u2013231","journal-title":"Lancet Oncol"},{"issue":"5","key":"4124_CR7","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1016\/j.ijrobp.2017.07.040","volume":"99","author":"A Sujenthiran","year":"2017","unstructured":"Sujenthiran A, Nossiter J, Charman SC, Parry M, Dasgupta P, van der Meulen J et al (2017) National population-based study comparing treatment-related toxicity in men who received intensity modulated versus 3-dimensional conformal radical radiation therapy for prostate cancer. Int J Radiat Oncol Biol Phys 99(5):1253\u20131260","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"4124_CR8","first-page":"256","volume":"42","author":"D Afonso-Jo\u00e3o","year":"2018","unstructured":"Afonso-Jo\u00e3o D, Pacheco-Figueiredo L, Antunes-Lopes T, Morgado LA, Azevedo V, Vendeira L et al (2018) Cumulative incidence and predictive factors of radiation cystitis in patients with localized prostate cancer. Actas Urol\u00f3gicas Espa\u00f1olas (Engl Edn) 42(4):256\u2013261","journal-title":"Actas Urol\u00f3gicas Espa\u00f1olas (Engl Edn)"},{"key":"4124_CR9","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/bju.14145","volume":"121","author":"JL Ma","year":"2018","unstructured":"Ma JL, Hennessey DB, Newell BP, Bolton DM, Lawrentschuk N (2018) Radiotherapy-related complications presenting to a urology department: a more common problem than previously thought? BJU Int 121:28\u201332","journal-title":"BJU Int"},{"issue":"1","key":"4124_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ijrobp.2009.07.1742","volume":"78","author":"BA Jereczek-Fossa","year":"2010","unstructured":"Jereczek-Fossa BA, Zerini D, Fodor C, Santoro L, Serafini F, Cambria R et al (2010) Correlation between acute and late toxicity in 973 prostate cancer patients treated with three-dimensional conformal external beam radiotherapy. Int J Radiat Oncol Biol Phys 78(1):26\u201334","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"4124_CR11","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1016\/j.ijrobp.2013.07.041","volume":"87","author":"JM Michalski","year":"2013","unstructured":"Michalski JM, Yan Y, Watkins-Bruner D, Bosch WR, Winter K, Galvin JM et al (2013) Preliminary toxicity analysis of 3-dimensional conformal radiation therapy versus intensity modulated radiation therapy on the high-dose arm of the Radiation Therapy Oncology Group 0126 Prostate Cancer Trial. Int J Radiat Oncol Biol Phys 87(5):932\u2013938","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"4124_CR12","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.radonc.2015.08.019","volume":"117","author":"S Sutani","year":"2015","unstructured":"Sutani S, Ohashi T, Sakayori M, Kaneda T, Yamashita S, Momma T et al (2015) Comparison of genitourinary and gastrointestinal toxicity among four radiotherapy modalities for prostate cancer: conventional radiotherapy, intensity-modulated radiotherapy, and permanent iodine-125 implantation with or without external beam radiotherapy. Radiother Oncol 117(2):270\u2013276","journal-title":"Radiother Oncol"},{"issue":"10","key":"4124_CR13","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1200\/JCO.2005.01.222","volume":"23","author":"GG Kimmick","year":"2005","unstructured":"Kimmick GG, Peterson BL, Kornblith AB, Mandelblatt J, Johnson JL, Wheeler J et al (2005) Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001. J Clin Oncol 23(10):2201\u20132207","journal-title":"J Clin Oncol"},{"issue":"13","key":"4124_CR14","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1200\/JCO.2005.00.141","volume":"23","author":"CA Townsley","year":"2005","unstructured":"Townsley CA, Selby R, Siu LL (2005) Systematic review of barriers to the recruitment of older patients with cancer onto clinical trials. J Clin Oncol 23(13):3112\u20133124","journal-title":"J Clin Oncol"},{"issue":"6","key":"4124_CR15","doi-asserted-by":"publisher","first-page":"e101176","DOI":"10.1371\/journal.pone.0101176","volume":"9","author":"SJ Sharp","year":"2014","unstructured":"Sharp SJ, Poulaliou M, Thompson SG, White IR, Wood AM (2014) A review of published analyses of case-cohort studies and recommendations for future reporting. PLoS ONE 9(6):e101176","journal-title":"PLoS ONE"},{"key":"4124_CR16","volume-title":"R: a language and environment for statistical computing","author":"R Core Team","year":"2020","unstructured":"R Core Team (2020) R: a language and environment for statistical computing. R Core Team, Vienna"},{"issue":"15","key":"4124_CR17","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1001\/jama.2012.460","volume":"307","author":"NC Sheets","year":"2012","unstructured":"Sheets NC, Goldin GH, Meyer AM, Wu Y, Chang Y, Sturmer T et al (2012) Intensity-modulated radiation therapy, proton therapy, or conformal radiation therapy and morbidity and disease control in localized prostate cancer. JAMA 307(15):1611\u20131620","journal-title":"JAMA"},{"issue":"3","key":"4124_CR18","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/S0167-8140(99)00100-0","volume":"55","author":"MJ Zelefsky","year":"2000","unstructured":"Zelefsky MJ, Fuks Z, Happersett L, Lee HJ, Ling CC, Burman CM et al (2000) Clinical experience with intensity modulated radiation therapy (IMRT) in prostate cancer. Radiother Oncol 55(3):241\u2013249","journal-title":"Radiother Oncol"},{"issue":"4","key":"4124_CR19","doi-asserted-by":"publisher","first-page":"e325","DOI":"10.1016\/j.ijrobp.2011.02.006","volume":"81","author":"JE Bekelman","year":"2011","unstructured":"Bekelman JE, Mitra N, Efstathiou J, Liao K, Sunderland R, Yeboa DN et al (2011) Outcomes after intensity-modulated versus conformal radiotherapy in older men with nonmetastatic prostate cancer. Int J Radiat Oncol Biol Phys 81(4):e325\u2013e334","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"14","key":"4124_CR20","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1001\/jama.2009.1451","volume":"302","author":"JC Hu","year":"2009","unstructured":"Hu JC, Gu X, Lipsitz SR, Barry MJ, D\u2019Amico AV, Weinberg AC et al (2009) Comparative effectiveness of minimally invasive vs open radical prostatectomy. JAMA 302(14):1557\u20131564","journal-title":"JAMA"},{"issue":"3","key":"4124_CR21","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/bju.14192","volume":"122","author":"M Chao","year":"2018","unstructured":"Chao M, Ho H, Chan Y, Tan A, Pham T, Bolton D et al (2018) Prospective analysis of hydrogel spacer for patients with prostate cancer undergoing radiotherapy. BJU Int 122(3):427\u2013433","journal-title":"BJU Int"},{"issue":"5","key":"4124_CR22","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/S1569-9056(14)61244-6","volume":"13","author":"C Cozzarini","year":"2014","unstructured":"Cozzarini C, Rancati T, Carillo V, Civardi F, Garibaldi E, Franco P et al (2014) Multi-variable models predicting specific patient-reported acute urinary symptoms after radiotherapy for prostate cancer: Ad interim results of a cohort study. Eur Urol Suppl 13(5):114\u2013115","journal-title":"Eur Urol Suppl"},{"issue":"3","key":"4124_CR23","first-page":"743","volume":"32","author":"R Mathieu","year":"2014","unstructured":"Mathieu R, Arango JD, Beckendorf V, Delobel JB, Messai T, Chira C et al (2014) Nomograms to predict late urinary toxicity after prostate cancer radiotherapy. World J Urol 32(3):743\u2013751","journal-title":"World J Urol"},{"issue":"1","key":"4124_CR24","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.radonc.2015.06.011","volume":"116","author":"N Yahya","year":"2015","unstructured":"Yahya N, Ebert MA, Bulsara M, Haworth A, Kennedy A, Joseph DJ et al (2015) Dosimetry, clinical factors and medication intake influencing urinary symptoms after prostate radiotherapy: an analysis of data from the RADAR prostate radiotherapy trial. Radiother Oncol 116(1):112\u2013118","journal-title":"Radiother Oncol"},{"issue":"3","key":"4124_CR25","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1016\/j.ijrobp.2010.05.040","volume":"79","author":"BA Jereczek-Fossa","year":"2011","unstructured":"Jereczek-Fossa BA, Orecchia R, Bonora M, Scardino E (2011) Response to \u201cUrinary obstruction in prostate cancer patients from the dutch trial (68 Gy vs. 78 Gy): relationships with local dose, acute effects, and baseline characteristics\u201d (Int J Radiat Oncol Biol Phys 2010;78:19\u201325). Int J Radiat Oncol Biol Phys 79(3):956","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"4124_CR26","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.clon.2017.03.006","volume":"29","author":"K Byrne","year":"2017","unstructured":"Byrne K, Hruby G, Kneebone A, Whalley D, Guo L, McCloud P et al (2017) Late genitourinary toxicity outcomes in 300 prostate cancer patients treated with dose-escalated image-guided intensity-modulated radiotherapy. Clin Oncol 29(9):617\u2013625","journal-title":"Clin Oncol"},{"issue":"9","key":"4124_CR27","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.clon.2016.04.041","volume":"28","author":"V Stankovic","year":"2016","unstructured":"Stankovic V, D\u017eamic Z, Pekmezovic T, Tepavcevic DK, Dozic M, Saric M et al (2016) Acute and late genitourinary toxicity after 72\u00a0Gy of conventionally fractionated conformal radiotherapy for localised prostate cancer: impact of individual and clinical parameters. Clin Oncol 28(9):577\u2013586","journal-title":"Clin Oncol"},{"issue":"6","key":"4124_CR28","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1016\/j.urology.2013.01.047","volume":"81","author":"K Kalakota","year":"2013","unstructured":"Kalakota K, Liauw SL (2013) Toxicity after external beam radiotherapy for prostate cancer: an analysis of late morbidity in men with diabetes mellitus. Urology 81(6):1196\u20131201","journal-title":"Urology"},{"issue":"1","key":"4124_CR29","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.ijrobp.2009.07.1680","volume":"78","author":"WD Heemsbergen","year":"2010","unstructured":"Heemsbergen WD, Al-Mamgani A, Witte MG, van Herk M, Pos FJ, Lebesque JV (2010) Urinary obstruction in prostate cancer patients from the Dutch trial (68 Gy vs. 78 Gy): relationships with local dose, acute effects, and baseline characteristics. Int J Radiat Oncol Biol Phys 78(1):19\u201325","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"4124_CR30","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1016\/j.clon.2011.03.001","volume":"23","author":"GC Barnett","year":"2011","unstructured":"Barnett GC, De Meerleer G, Gulliford SL, Sydes MR, Elliott RM, Dearnaley DP (2011) The impact of clinical factors on the development of late radiation toxicity: results from the Medical Research Council RT01 trial (ISRCTN47772397). Clin Oncol 23(9):613\u2013624","journal-title":"Clin Oncol"},{"issue":"2","key":"4124_CR31","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.ijrobp.2007.10.004","volume":"71","author":"O Cahlon","year":"2008","unstructured":"Cahlon O, Zelefsky MJ, Shippy A, Chan H, Fuks Z, Yamada Y et al (2008) Ultra-high dose (86.4\u00a0Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomes. Int J Radiat Oncol Biol Phys 71(2):330\u2013337","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"4124_CR32","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.ijrobp.2013.03.020","volume":"86","author":"AA Ahmed","year":"2013","unstructured":"Ahmed AA, Egleston B, Alcantara P, Li L, Pollack A, Horwitz EM et al (2013) A novel method for predicting late genitourinary toxicity after prostate radiation therapy and the need for age-based risk-adapted dose constraints. Int J Radiat Oncol Biol Phys 86(4):709\u2013715","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"4124_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.ijrobp.2010.09.027","volume":"82","author":"C Cozzarini","year":"2012","unstructured":"Cozzarini C, Fiorino C, Da Pozzo LF, Alongi F, Berardi G, Bolognesi A et al (2012) Clinical factors predicting late severe urinary toxicity after postoperative radiotherapy for prostate carcinoma: a single-institute analysis of 742 patients. Int J Radiat Oncol Biol Phys 82(1):191\u2013199","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"14","key":"4124_CR34","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1016\/j.ejca.2011.12.034","volume":"48","author":"LJ Wedlake","year":"2012","unstructured":"Wedlake LJ, Silia F, Benton B, Lalji A, Thomas K, Dearnaley DP et al (2012) Evaluating the efficacy of statins and ACE-inhibitors in reducing gastrointestinal toxicity in patients receiving radiotherapy for pelvic malignancies. Eur J Cancer 48(14):2117\u20132124","journal-title":"Eur J Cancer"},{"issue":"3","key":"4124_CR35","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1016\/j.ijrobp.2005.02.050","volume":"63","author":"JB Ashman","year":"2005","unstructured":"Ashman JB, Zelefsky MJ, Hunt MS, Leibel SA, Fuks Z (2005) Whole pelvic radiotherapy for prostate cancer using 3D conformal and intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 63(3):765\u2013771","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"4124_CR36","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.radonc.2007.07.013","volume":"84","author":"C Cozzarini","year":"2007","unstructured":"Cozzarini C, Fiorino C, Di Muzio N, Alongi F, Broggi S, Cattaneo M et al (2007) Significant reduction of acute toxicity following pelvic irradiation with helical tomotherapy in patients with localized prostate cancer. Radiother Oncol 84(2):164\u2013170","journal-title":"Radiother Oncol"},{"issue":"4","key":"4124_CR37","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/0360-3016(94)90100-7","volume":"28","author":"CA Perez","year":"1994","unstructured":"Perez CA, Lee HK, Georgiou A, Lockett MA (1994) Technical factors affecting morbidity in definitive irradiation for localized carcinoma of the prostate. Int J Radiat Oncol Biol Phys 28(4):811\u2013819","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"4124_CR38","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.ijrobp.2004.07.715","volume":"61","author":"STH Peeters","year":"2005","unstructured":"Peeters STH, Heemsbergen WD, van Putten WLJ, Slot A, Tabak H, Mens JW et al (2005) Acute and late complications after radiotherapy for prostate cancer: results of a multicenter randomized trial comparing 68 Gy to 78 Gy. Int J Radiat Oncol Biol Phys 61(4):1019\u20131034","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"6","key":"4124_CR39","doi-asserted-by":"publisher","first-page":"324","DOI":"10.1159\/000362858","volume":"37","author":"CM Acevedo-Henao","year":"2014","unstructured":"Acevedo-Henao CM, Lopez Guerra JL, Matute R, Puebla F, Russo M, Rivin E et al (2014) Image-guided radiation therapy based on helical tomotherapy in prostate cancer: minimizing toxicity. Oncol Res Treat 37(6):324\u2013330","journal-title":"Oncol Res Treat"},{"issue":"2","key":"4124_CR40","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.ijrobp.2016.10.024","volume":"97","author":"N Yahya","year":"2017","unstructured":"Yahya N, Ebert MA, House MJ, Kennedy A, Matthews J, Joseph DJ et al (2017) Modeling urinary dysfunction after external beam radiation therapy of the prostate using bladder dose-surface maps: evidence of spatially variable response of the bladder surface. Int J Radiat Oncol Biol Phys 97(2):420\u2013426","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"SUPPL. 1","key":"4124_CR41","doi-asserted-by":"publisher","first-page":"S193","DOI":"10.1016\/j.brachy.2016.04.354","volume":"15","author":"S Aluwini","year":"2016","unstructured":"Aluwini S, Lopes AR, Sipkema DJ, Roos MA, Busser WMH, Kolkman-Deurloo IKK (2016) Predictive factors for urinary retention after HDR brachytherapy as monotherapy for prostate cancer. Brachytherapy 15(SUPPL. 1):S193\u2013S194","journal-title":"Brachytherapy"},{"issue":"1","key":"4124_CR42","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ijrobp.2011.11.047","volume":"84","author":"MJ Zelefsky","year":"2012","unstructured":"Zelefsky MJ, Kollmeier M, Cox B, Fidaleo A, Sperling D, Pei X et al (2012) Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer. Int J Radiat Oncol Biol Phys 84(1):125\u2013129","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"4124_CR43","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ijrobp.2008.10.086","volume":"75","author":"C Fiorino","year":"2009","unstructured":"Fiorino C, Alongi F, Perna L, Broggi S, Cattaneo GM, Cozzarini C et al (2009) Dose-volume relationships for acute bowel toxicity in patients treated with pelvic nodal irradiation for prostate cancer. Int J Radiat Oncol Biol Phys 75(1):29\u201335","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"4124_CR44","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.radonc.2010.08.002","volume":"97","author":"T Rosewall","year":"2010","unstructured":"Rosewall T, Catton C, Currie G, Bayley A, Chung P, Wheat J et al (2010) The relationship between external beam radiotherapy dose and chronic urinary dysfunction\u2014a methodological critique. Radiother Oncol 97(1):40\u201347","journal-title":"Radiother Oncol"},{"issue":"2","key":"4124_CR45","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.urology.2013.02.071","volume":"82","author":"JM Sewell","year":"2013","unstructured":"Sewell JM, Rao A, Elliott SP (2013) Validating a claims-based method for assessing severe rectal and urinary adverse effects of radiotherapy. Urology 82(2):335\u2013340","journal-title":"Urology"},{"issue":"33","key":"4124_CR46","doi-asserted-by":"publisher","first-page":"5298","DOI":"10.1200\/JCO.2006.07.9954","volume":"24","author":"AB Chen","year":"2006","unstructured":"Chen AB, D\u2019Amico AV, Neville BA, Earle CC (2006) Patient and treatment factors associated with complications after prostate brachytherapy. J Clin Oncol 24(33):5298","journal-title":"J Clin Oncol"},{"issue":"4","key":"4124_CR47","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S0094-0143(05)70339-6","volume":"23","author":"GE Hanks","year":"1996","unstructured":"Hanks GE (1996) Long-term control of prostate cancer with radiation: past, present, and future. Urol Clin N Am 23(4):605\u2013616","journal-title":"Urol Clin N Am"},{"issue":"1","key":"4124_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.radonc.2007.02.014","volume":"83","author":"DP Dearnaley","year":"2007","unstructured":"Dearnaley DP, Sydes MR, Langley RE, Graham JD, Huddart RA, Syndikus I et al (2007) The early toxicity of escalated versus standard dose conformal radiotherapy with neo-adjuvant androgen suppression for patients with localised prostate cancer: results from the MRC RT01 trial (ISRCTN47772397). Radiother Oncol 83(1):31\u201341","journal-title":"Radiother Oncol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-022-04124-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-022-04124-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-022-04124-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,26]],"date-time":"2022-09-26T16:09:24Z","timestamp":1664208564000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-022-04124-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,11]]},"references-count":48,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2022,10]]}},"alternative-id":["4124"],"URL":"https:\/\/doi.org\/10.1007\/s00345-022-04124-x","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,11]]},"assertion":[{"value":"9 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The SA-PCCOC database has been approved by the Southern Adelaide Clinical Human Research Ethics Committee (SAC HREC). Approval to access the database was granted by the SA-PCCOC steering committee. The study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"The authors have no competing interests to declare that are relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}